New LEVEL UP Period 2 Data Shows Patients Who Switched From Dupilumab to Upadacitinib Achieved Higher Treatment Targets in AD

Press/Media

Period1 Oct 2024

Media coverage

1

Media coverage

  • TitleNew LEVEL UP Period 2 Data Shows Patients Who Switched From Dupilumab to Upadacitinib Achieved Higher Treatment Targets in AD
    Media name/outletDermatology Times
    Country/TerritoryUnited States
    Date1/10/24
    PersonsNiamh Moore
View all 1
View less